- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06351202
Impact Assessment of Abdominal Massage on Feeding Tolerance of Preterms (PREMABDO)
Impact Assessment of Abdominal Massage on the Feeding Tolerance of Preterms (Less Than 34 Weeks of Amenorrhea) : a Randomized, Single-blind Controlled Trial
Every year in France, 60,000 children are born prematurely (before 37 weeks of amenorrhea - WA), and present an immaturity of their various systems, in particular the digestive system. This can result in feeding intolerance, expressed by abdominal distension, regurgitation, irregular transit and abdominal discomfort. It can influence the length of hospitalization and lead to necrotising enterocolitis, a major complication.
At the Clermont-Ferrand University Hospital Center, abdominal massages have been performed by physiotherapist for several years in order to improve the state of the digestive system of preterm infants. The indication for abdominal massages are very dependent on the caregivers in charge of the newborns because the evaluation of feeding intolerance remains subjective.
In this context, the investigators carried out a first study to validate a scale that they created (ECAP scale : Clinical Assessment Scale for Abdominal state of Preterm infant) to assess in a rapid, reliable and reproductible manner the abdominal state of preterm infant - data currently being published). This scale can pose the indications for abdominal massage more objectively.
The hypothesis is that abdominal massage improves feeding tolerance (decrease ECAP score), allows faster weight gain and reaching the full ration and therefore reduces the length of hospitalization of preterm infants.
The aim of the study is to assess the effectiveness of abdominal massage, over a period of 14 days, on the feeding tolerance of preterm infants (under 34 weeks of amenorrhea), defined by the achievement and maintenance of an ECAP score less than 4 during 3 days.
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a single-blind, randomized controlled study. The children will be recruited in the Neonatal Intensive Care Units of the investigation center, by the nursing staff carrying out the ECAP assessment (physiotherapists, nurses, doctors).
An information note will be presented and explained by an element of the medical or paramedical staff to the parents. After a 24 hours reflexion period and answer to any questions they may have, written and informed consent will be requested from both parents for their child's participation in this study.
After obtaining the signed consents, the randomization will follow. In the first group, preterm infants with feeding intolerance will not be massed.
In the second group, at least 10 abdominal massages will be performed by a physiotherapist trained in this technique over a period of 14 days, at the rate of one massage per day.
Each day, the ECAP assessment will be performed at t0min (just before performing an abdominal massage in the massed group) and at t10min (just after performing the massage). The investigators estimate that an abdominal massage for premature babies lasts 10 minutes. The abdominal massage techniques will be adapted according to the term of the child.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France
- Recruiting
- CHU Clermont-Ferrand
-
Principal Investigator:
- Marie COLNE
-
Contact:
- Lise LACLAUTRE
- Phone Number: 334.73.754.963
- Email: llaclautre_perrier@chu-clermontferrand.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Newborn, premature, less than 34 Weeks of Amennorhea
- at least 3 days of life
- hospitalized in neonatal intensive care units
- with feeding intolerance demonstrated by an ECAP (Clinical Abdominal Assessement scale for preterms) score equal to or greater than 4/20
- whose holders of parental authority are able to give free and informed consent to participate in this study.
Exclusion Criteria:
- premature newborns with a congenital pathology such as malformation, genetic or chromosomal abnormality
- newborns whose holders of parental authority are protected by law (under guardianship, curatorship, placed under judicial safeguard) or aged under 18
- rejection of participation by parents
- newborns with a contraindication to abdominal massage (fever, major hemodynamic instability)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No abdominal massage group
During 14 days, preterm infants with feeding intolerance will not be massed by physiotherapists.
|
|
|
Experimental: Abdominal massage group
At least 10 abdominal massages will be performed on preterms, by a physiotherapist trained in this technique over a period of 14 days, at the rate of one massage per day.
|
An abdominal massage for premature babies lasts 10 minutes.
Our abdominal massage techniques is described in our protocole and will be adapted according to the term of the child.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Abdominal assessment scale for Preterm infants score (ECAP score)
Time Frame: twice day during 14 days
|
score between 0 and 20
|
twice day during 14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Variation of the ECAP score (Clinical Abdominal assessement scale for preterms score) between t0 minute and t10 minutes
Time Frame: up to 14 days
|
score between 0 and 20
|
up to 14 days
|
|
Weight gain of preterm infants with feeding intolerance
Time Frame: up to 28 days
|
Daily weight of preterm infants, in z-score
|
up to 28 days
|
|
Duration to reach the full ration
Time Frame: up to 28 days
|
Number of days needed to reach the full ration (120mL/kg/day)
|
up to 28 days
|
|
Duration of hospitalization in level 3
Time Frame: up to 3 months
|
Total number of days of hospitalization in level 3
|
up to 3 months
|
|
6-hour fasting windows
Time Frame: up to 28 days
|
Number of 6-hour fasting windows
|
up to 28 days
|
|
Incidence of occurrence of necrotizing enterocolitis
Time Frame: up to 28 days
|
number of necrotizing enterocolitis
|
up to 28 days
|
|
Evolution of digestive tolerance over time
Time Frame: up to 28 days
|
Raw ECAP value at t10 minutes over time
|
up to 28 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RBGP 2023 COLNE
- 2023-A02256-39 (Other Identifier: ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Digestive System Disease
-
Changhai HospitalCompletedDiagnoses Disease | Digestive System DiseaseChina
-
Pharmbio Korea Co., Ltd.Not yet recruitingColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
Pharmbio Korea Co., Ltd.CompletedColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
Pharmbio Korea Co., Ltd.RecruitingColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
GCS Ramsay Santé pour l'Enseignement et la RechercheEuraxi PharmaNot yet recruitingSurgery | Digestive System DiseaseFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
University of MalagaCompleted
-
IpsenCompletedDigestive System DiseaseCzechia, France, Germany, Poland, Netherlands, Italy
-
Hôpital Edouard HerriotCompletedDigestive System DiseaseFrance
-
Amway CorpCitruslabsCompletedDigestive System DiseaseUnited States
Clinical Trials on Abdominal massage
-
TC Erciyes UniversityCompletedAbdominal Pain | Satisfaction, Patient | DistentionTurkey
-
University of PotsdamNot yet recruitingDysmenorrhea | Dysmenorrhea Primary | Dysmenorrhea Secondary | Dysmenorrhea Symptom
-
Mersin UniversityRecruitingGastrointestinal Motility Disorder | Defecation Disorder | Gastrointestinal Motility and Defecation ConditionsTurkey
-
Burcu OzkanCompletedConstipation | StoolTurkey (Türkiye)
-
Marmara UniversityCompletedEnteral Nutrition | Gastric Residual Volume | Massage Therapy | Abdominal DistensionTurkey
-
Prof. Dr. Cemil Tascıoglu Education and Research...Completed
-
Glasgow Caledonian UniversityNHS Greater Glasgow and Clyde; Baily Thomas Charitable FundCompletedConstipationUnited Kingdom
-
Marmara UniversityIstanbul University - CerrahpasaRecruiting
-
Air Force Military Medical University, ChinaRecruitingCommon Bile Duct Stone | Abdominal MassageChina
-
Firat TukenmezCompleted